BioStar Capital
Overview
BioStar Capital is a uniquely structured venture capital firm focused on transformative medical technologies. Their team includes renowned healthcare clinicians and executives, medical thought leaders, and financial professionals, differentiating the firm within the industry and mitigating risk through its connected network and disciplined investment process. They invest in and nurtures transformative medical technologies with a primary emphasis on the cardiovascular and orthopedic sectors, the firm also invests in digital health, robotics, ophthalmology, neuromodulation, and biomaterials.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Nectero Therapeutics | Apr 2024 | Series D | Co-investor |
| Trice Medical | Jan 2019 | Series C Extension | Co-investor |
| Versa Vascular, Inc. | Aug 2026 | Series C | Lead |
| Field Medical | Jul 2025 | Series B | Lead |
| Aria CV | Aug 2025 | Series C | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is BioStar Capital based?
BioStar Capital is headquartered in Charlevoix, Michigan, United States.
When was BioStar Capital founded?
BioStar Capital was founded in 2005.
How many portfolio companies does BioStar Capital have?
BioStar Capital has 14 portfolio companies in Caplight's dataset.
What are some companies in BioStar Capital's portfolio?
Portfolio companies visible on Caplight include Nectero Therapeutics, Trice Medical, Versa Vascular, Inc., Field Medical, Aria CV.
What was BioStar Capital's most recent investment shown here?
BioStar Capital's most recent investment in this portfolio sample was in Versa Vascular, Inc. in 2026.
What sectors does BioStar Capital focus on?
BioStar Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does BioStar Capital focus on?
BioStar Capital typically invests at the Mid stage.
What is BioStar Capital's AUM?
BioStar Capital's assets under management are estimated between $100.0M and $250.0M.